---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-000240"
form_type: "8-K"
ticker: "AURX"
cik: "0001091596"
company_name: "Nuo Therapeutics, Inc."
filed_at: "2022-01-04T23:59:59+00:00"
generated_at: "2026-06-27T20:51:15.720860+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nuo Therapeutics modifies warrant exercise price; all warrants exercised for 6.87M shares and $1.37M

## Summary
- Warrant exercise price reduced from $0.40 to $0.20 per share, with exercise required by Jan 31, 2022.
- All 6,865,461 warrants exercised by Dec 30, 2021, raising $1,373,092 in gross proceeds.
- Company issued 6.87M shares of common stock in exempt private placement under Section 4(a)(2) and 3(a)(9).
- Warrants were originally issued in October 2020 recapitalization and for services to executives including CEO David Jorden.

## SEC filing metadata
- accession: 0001437749-22-000240
- form_type: 8-K
- ticker: AURX
- cik: 0001091596
- company_name: Nuo Therapeutics, Inc.
- filed_at: 2022-01-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1091596/000143774922000240/0001437749-22-000240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1091596/000143774922000240/aurx20220103_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-000240
- JSON: https://secwatch.observer/filing/0001437749-22-000240.json
- Plain text: https://secwatch.observer/filing/0001437749-22-000240.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.